DaVita (DVA) Misses Q3 EPS by 13c, Beats on Revenue
Tweet
Share
E-mail
Get Alerts DVA Hot Sheet
Price: $179.17 -1.28%
Financial Fact:
Patient care costs: 2.7B
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Patient care costs: 2.7B
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
DaVita (NYSE: DVA) reported Q3 EPS of $2.59, $0.13 worse than the analyst estimate of $2.72. Revenue for the quarter came in at $3.26 billion versus the consensus estimate of $3.25 billion.
For earnings history and earnings-related data on DaVita (DVA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Kodiak Sciences Inc. (KOD) Misses Q2 EPS by 7c
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
